Canada markets closed

Madrigal Pharmaceuticals, Inc. (MDGL)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
229.84+13.79 (+6.38%)
At close: 04:00PM EDT
231.00 +1.16 (+0.50%)
After hours: 06:51PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 4.89B
Enterprise Value 4.38B
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)12.07
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -12.14

Trading Information

Stock Price History

Beta (5Y Monthly) -0.44
52-Week Change 3-30.05%
S&P500 52-Week Change 322.38%
52 Week High 3313.11
52 Week Low 3119.76
50-Day Moving Average 3240.76
200-Day Moving Average 3201.26

Share Statistics

Avg Vol (3 month) 3616.32k
Avg Vol (10 day) 3516.92k
Shares Outstanding 521.28M
Implied Shares Outstanding 621.28M
Float 812.31M
% Held by Insiders 115.37%
% Held by Institutions 193.12%
Shares Short (Apr 15, 2024) 43.41M
Short Ratio (Apr 15, 2024) 46.17
Short % of Float (Apr 15, 2024) 419.29%
Short % of Shares Outstanding (Apr 15, 2024) 416.24%
Shares Short (prior month Mar 15, 2024) 43.26M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Jul 25, 2016
Ex-Dividend Date 4N/A
Last Split Factor 21:35
Last Split Date 3Jul 25, 2016

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-47.41%
Return on Equity (ttm)-123.98%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -379.97M
Net Income Avi to Common (ttm)-373.63M
Diluted EPS (ttm)-20.00
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)634.13M
Total Cash Per Share (mrq)31.87
Total Debt (mrq)117.19M
Total Debt/Equity (mrq)28.91%
Current Ratio (mrq)5.38
Book Value Per Share (mrq)20.39

Cash Flow Statement

Operating Cash Flow (ttm)-324.23M
Levered Free Cash Flow (ttm)-192.38M